These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35930367)

  • 21. Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression.
    Guo Z; Wang F; Di Y; Yao L; Yu X; Fu D; Li J; Jin C
    Int J Nanomedicine; 2018; 13():4869-4880. PubMed ID: 30214194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
    Lee GY; Qian WP; Wang L; Wang YA; Staley CA; Satpathy M; Nie S; Mao H; Yang L
    ACS Nano; 2013 Mar; 7(3):2078-89. PubMed ID: 23402593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway.
    Zhang J; Xu HX; Cho WCS; Cheuk W; Li Y; Huang QH; Yang W; Xian YF; Lin ZX
    J Exp Clin Cancer Res; 2022 Mar; 41(1):90. PubMed ID: 35272669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
    Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A novel gemcitabine delivery system].
    Sugitachi A; Ikeda M; Matsuo T; Nishizuka S; Nitta H; Takahashi M; Takahara T; Ito N; Hasegawa Y; Wakabayashi G
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2445-7. PubMed ID: 22202408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-Healing pH- and Enzyme Stimuli-Responsive Hydrogels for Targeted Delivery of Gemcitabine To Treat Pancreatic Cancer.
    Bilalis P; Skoulas D; Karatzas A; Marakis J; Stamogiannos A; Tsimblouli C; Sereti E; Stratikos E; Dimas K; Vlassopoulos D; Iatrou H
    Biomacromolecules; 2018 Sep; 19(9):3840-3852. PubMed ID: 30095907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
    Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
    Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment.
    Kong X; Feng M; Wu L; He Y; Mao H; Gu Z
    Drug Deliv; 2022 Dec; 29(1):1595-1607. PubMed ID: 35612309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
    Ma T; Jiang JL; Qi WX; Chen JY; Xu HP
    Drug Des Devel Ther; 2022; 16():2395-2406. PubMed ID: 35923931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatment.
    Han H; Wang J; Chen T; Yin L; Jin Q; Ji J
    J Colloid Interface Sci; 2017 Dec; 507():217-224. PubMed ID: 28800445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
    Zhuang B; Chen T; Xiao Z; Jin Y
    Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-Delivery of Gemcitabine and Mcl-1 SiRNA via Cationic Liposome-Based System Enhances the Efficacy of Chemotherapy in Pancreatic Cancer.
    Wang Y; Gao F; Jiang X; Zhao X; Wang Y; Kuai Q; Nie G; He M; Pan Y; Shi W; Ren S; Yu Q
    J Biomed Nanotechnol; 2019 May; 15(5):966-978. PubMed ID: 30890228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer.
    Kawaguchi K; Miyake K; Han Q; Li S; Tan Y; Igarashi K; Kiyuna T; Miyake M; Higuchi T; Oshiro H; Zhang Z; Razmjooei S; Wangsiricharoen S; Bouvet M; Singh SR; Unno M; Hoffman RM
    Cancer Lett; 2018 Sep; 432():251-259. PubMed ID: 29928962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
    Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
    Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.
    Li Y; Chen Y; Li J; Zhang Z; Huang C; Lian G; Yang K; Chen S; Lin Y; Wang L; Huang K; Zeng L
    Cancer Sci; 2017 Jul; 108(7):1493-1503. PubMed ID: 28444967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer.
    Miyashita T; Miki K; Kamigaki T; Makino I; Nakagawara H; Tajima H; Takamura H; Kitagawa H; Fushida S; Ahmed AK; Duncan MD; Harmon JW; Ohta T
    Clin Exp Med; 2017 Feb; 17(1):19-31. PubMed ID: 26449615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trans-tissue, sustained release of gemcitabine from photocured gelatin gel inhibits the growth of heterotopic human pancreatic tumor in nude mice.
    Okino H; Maeyama R; Manabe T; Matsuda T; Tanaka M
    Clin Cancer Res; 2003 Nov; 9(15):5786-93. PubMed ID: 14654564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigations of potent biocompatible metal-organic framework for efficient encapsulation and delivery of Gemcitabine: biodistribution, pharmacokinetic and cytotoxicity study.
    Kush P; Kaur M; Sharma M; Madan J; Kumar P; Deep A; Kim KH
    Biomed Phys Eng Express; 2020 Feb; 6(2):025014. PubMed ID: 33438640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer.
    Zhao X; Li F; Li Y; Wang H; Ren H; Chen J; Nie G; Hao J
    Biomaterials; 2015 Apr; 46():13-25. PubMed ID: 25678112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.